Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://jmc.elmerpub.com

Case Report

Volume 16, Number 4, April 2025, pages 127-130

Inadvertent Intra-Arterial Administration of Rocuronium During Anesthetic Care in a Sixteen-Year-Old Patient

Table

Table 1. Case Reports of Intra-Arterial Administration of Neuromuscular Blocking Agents
 
AuthorPatient demographics and surgical procedureClinical course and outcome
BMI: body mass index; IA: intra-arterial; ORIF: open reduction, internal fixation.
Nicolson et al [3]An 8-day-old, 2.7 kg neonate with hypoplastic left heart syndrome presenting for stage I palliationIntentional IA administration of pancuronium (0.15 mg/kg) and fentanyl through a radial artery prior to cardiac surgery.
Joshi and Tobias [4]A 10-month-old, 7.6 kg infant and a 12-month-old, 8.2 kg infant presenting for Blalock-Taussig shuntIntentional IA administration of 1 or 1.5 mg vecuronium in femoral artery. No long-term sequelae.
Rao [5]A 59-year-old, 101 kg man for emergent coronary revascularizationIntentional IA administration of rocuronium (60 mg) via the radial artery. No long-term sequelae.
Shukla et al [6]An 8-year-old, 45 kg girl for ORIF of the clavicleInadvertent IA administration of rocuronium (50 mg) through a catheter in the antecubital fossa. Inadvertent IA placement due to patient’s high BMI and uncooperative state. No long-term sequelae.
Kessell and Barker [7]An 11-month-old, 10.4 kg toddler for tonsillectomyInadvertent IA administration of succinylcholine (20 mg) and atracurium (3 mg) via the femoral artery. Transient blanching and ischemic changes of leg. No long-term sequelae.
Gorman and Dearlove [8]A 30-month-old, 8.3 kg toddler for reduction of congenital hip dislocationInadvertent IA administration of atracurium (0.5 mg/kg) via the brachial artery. No long-term sequalae.
Devlin and Bali [9]A 28-year-old man for tonsillectomyInadvertent IA administration of tubocurarine (4 mg) in the antecubital fossa. No long-term sequalae.